Derek A Mann

Prof. Derek A Mann


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2023 in Nature
Verified
Journal Article
Open access
PDF file
SVStella Victorelli
Stella Victorelli
HSHanna Salmonowicz
Hanna Salmonowicz
JCJames Chapman
James Chapman
HMHelene Martini
Helene Martini
MVMaria Grazia Vizioli
Maria Grazia Vizioli
JPJoão F. Passos
João F. Passos
Senescent cells drive age-related tissue dysfunction partially through the induction of a chronic senescence-associated secretory phenotype (SASP)1. Mitochondria are major regulators of the SASP; however, the underlying mechanisms have not been elucidated2. Mitochondria are often essential for apoptosis, a cell fate distinct from cellular senescence. During apoptosis, widespread mitochondrial outer membrane permeabilization (MOMP) commits a cell to die3. Here we find that MOMP occurring in a subset of mitochondria is a feature of cellular senescence. This process, called minority MOMP (miMOMP), requires BAX and BAK macropores enabling the release of mitochondrial DNA (mtDNA) into the cytosol. Cytosolic mtDNA in turn activates the cGAS–STING pathway, a major regulator of the SASP. We find that inhibition of MOMP in vivo decreases inflammatory markers and improves healthspan in aged mice. Our results reveal that apoptosis and senescence are regulated by similar mitochondria-dependent mechanisms and that sublethal mitochondrial apoptotic stress is a major driver of the SASP. We provide proof-of-concept that inhibition of miMOMP-induced inflammation may be a therapeutic route to improve healthspan.

1 August 2007 in Hepatology
Verified
Journal Article
Closed access
PDF file
AEAhmed M. Elsharkawy
Ahmed M. Elsharkawy
DMDerek A Mann
Derek A Mann

2 September 2012 in Nature Medicine
Verified
Journal Article
Open access
PDF file
MZMüjdat Zeybel
Müjdat Zeybel
THTimothy Hardy
Timothy Hardy
YWYi K Wong
Yi K Wong
JMJohn Mathers
John Mathers
CFChristopher R Fox
Christopher R Fox
JMJelena Mann
Jelena Mann
Derek Mann and his colleagues have found that experimental induction of liver fibrosis in male rats results in an epigenetic modification of the chromatin in their sperm such that their offspring have a more mild wound-healing response to hepatic fibrogenic insults. The mechanism responsible for this phenomenon is not clear, but it seems to involve a yet unidentified soluble factor released by myofibroblasts that act on either the germ cells or mature sperm. We investigated whether ancestral liver damage leads to heritable reprogramming of hepatic wound healing in male rats. We found that a history of liver damage corresponds with transmission of an epigenetic suppressive adaptation of the fibrogenic component of wound healing to the male F1 and F2 generations. Underlying this adaptation was less generation of liver myofibroblasts, higher hepatic expression of the antifibrogenic factor peroxisome proliferator-activated receptor γ (PPAR-γ) and lower expression of the profibrogenic factor transforming growth factor β1 (TGF-β1) compared to rats without this adaptation. Remodeling of DNA methylation and histone acetylation underpinned these alterations in gene expression. Sperm from rats with liver fibrosis were enriched for the histone variant H2A.Z and trimethylation of histone H3 at Lys27 (H3K27me3) at PPAR-γ chromatin. These modifications to the sperm chromatin were transmittable by adaptive serum transfer from fibrotic rats to naive rats and similar modifications were induced in mesenchymal stem cells exposed to conditioned media from cultured rat or human myofibroblasts. Thus, it is probable that a myofibroblast-secreted soluble factor stimulates heritable epigenetic signatures in sperm so that the resulting offspring better adapt to future fibrogenic hepatic insults. Adding possible relevance to humans, we found that people with mild liver fibrosis have hypomethylation of the PPARG promoter compared to others with severe fibrosis.

12 January 2022 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
DGDaniel Geh
Daniel Geh
JLJack Leslie
Jack Leslie
RRRob Rumney
Rob Rumney
Helen L. ReevesHelen L. Reeves
Helen L. Reeves
TBThomas G. Bird
Thomas G. Bird
DMDerek A Mann
Derek A Mann

27 November 2011 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MEMohammad R Ebrahimkhani
Mohammad R Ebrahimkhani
FOFiona Oakley
Fiona Oakley
LMLindsay B Murphy
Lindsay B Murphy
JMJelena Mann
Jelena Mann
AMAnna Moles
Anna Moles
DMDerek A Mann
Derek A Mann

25 March 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ALAnthony Lagnado
Anthony Lagnado
JLJack Leslie
Jack Leslie
MRMarie‐Helene Ruchaud‐Sparagano
Marie‐Helene Ruchaud‐Sparagano
SVStella Victorelli
Stella Victorelli
PHPetra Hirsova
Petra Hirsova
JPJoão F Passos
João F Passos
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.